Abstract

Mini Review

Which is the best? Palliative Radiation Therapy to Spleen or Splenectomy

Yasemin Benderli Cihan*

Published: 09 February, 2018 | Volume 2 - Issue 1 | Pages: 003-008

Spleen is one of the most important organ of the reticuloendothelial system and coordinates the immune response. Splenectomy is performed for hypersplenism, and staging of hematological malignancy. In conservatively followed patients, radiation therapy can be used to reduce hypersplenism symptoms. Splenectomy or palliative radiotherapy to spleen may probably cause an immune suppressive condition. This may probably local and systemic complications.

Read Full Article HTML DOI: 10.29328/journal.jro.1001015 Cite this Article Read Full Article PDF

Keywords:

Spleen, reticuloendothelial system, gastrointestinal malignancies, splenic irradiation

References

  1. Mogestern L. A history of splenectomy, in Hiatt JR, Philips EH, Morgenstern L (eds): sutgical Diseases of the S      pleen. Berlin-Heidelberg-Verlag. 1997; 3.
  2. Mebius RE, Kraal G. Structure and function of the spleen. Nature Rev Immunol. 2005; 5: 606-616. Ref.: https://goo.gl/yz37Qi
  3. Bowdler AJ (editör). The Complete Spleen: Structure, Function, and clinical Disorders. Humana Press, Totowa, NJ (2nd edition). 2002; 140: 18-47.
  4. Rubin LG, Schaffner W. Clincial practice. Care of the asplenic patient. N Eng J Med. 2014; 371: 349-56. Ref.: https://goo.gl/wZ3UW2
  5. Altamura M,  Caradonna  L,  Amati  L,  Pellegrino  NM,  Urgesi  G, et al. Splenectomy and sepsis: the role of the spleen in the immune-mediated bacterial  clearance. Immunopharmacol Immunotoxicol. 2001; 23: 153-61. Ref.: https://goo.gl/p63YLC
  6. Cihan YB, Yokus O, Mutlu H. The role of palliative radiotherpy in symptomatic splenomegaly developing among elderly patients with chronic myleoproliferative disorders. Turkish Journal of Geriatrics. 2012; 15: 34-39.
  7. Wardemann H, Boehm T, Dear N, Carsetti R. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen.  The Journal of Experimental Medicine. 2002; 195: 771. Ref.: https://goo.gl/8YzkKy
  8. Pozo AL, Godfrey EM, Bowles KM. Splenomegaly: investigation, diagnosis and management. Blood Rev. 2009; 23: 105-111. Ref.: https://goo.gl/a9u19a
  9. Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet. 2011; 378: 86-97. Ref.: https://goo.gl/btiRav
  10. Ziemski JM, Rudowsi WJ. Evaluation of early postsplenektomy complications. Surg Gyne Obs. 1987; 165: 507-515.
  11. Rogers ZR, Wang WC, Luo Z, Iyer RV, Shalaby-Rana E, et al. Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial. Blood. 2011; 117: 2614-2617. Ref.: https://goo.gl/VVbd8v
  12. Bronte V, Pittet MJ. The spleen in local and systemic regulation of immunity. Immunity. 2013; 39: 806-818. Ref.: https://goo.gl/KakxSU
  13. Trip AK, Sikorska K, van Sandick JW, Heeg M, Cats A, et al. Radiation-induced dose-dependent changes of the spleen following postoperative chemoradiotherapy for gastric cancer. Radiother Oncol. 2015; 116: 239-244. Ref.: https://goo.gl/qUEaJs
  14. Schwartz PE, Sterioff S, Mucha P, Melton 3rd LJ, Offord KP. Postsplenectomy sepsis and mortality in adults. JAMA. 1982; 248: 2279-2283. Ref.: https://goo.gl/FQcqRv
  15. Wen SW, Everitt SJ, Bedő J, Chabrot M, Ball DL, et al. Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy. PLoS One. 2015; 10: 0142608. Ref.: https://goo.gl/9fwLuN
  16. Molrine DC, Siber GR, Samra Y, Shevy DS, MacDonald K, et al.  Normal  IgG  and  impaired  IgM  responses  to  polysaccharide  vaccines  in asplenic patients. Journal of Infectious Diseases. 1999; 179: 513-517. Ref.: https://goo.gl/CMAkWL
  17. Davies J,  Barnes  R,  Milligan  D.  Update  of  guidelines  for  the  prevention  and treatment of infection in patients with an absent or dysfunctional spleen.  Clinical Medicine. Clin Med (Lond). 2002; 2: 440-443. Ref.: https://goo.gl/azcNWK
  18. Newland  A,  Provan  D,  Myint  S.  Preventing  severe  infection  after  splenectomy: Patients should know the risks, be immunised, and take prophylactic antibiotics. BMJ: British Medical Journal. 2005; 331: 417. Ref.: https://goo.gl/nGp9au
  19. Styrt B. Infection associated with asplenia: risks, mechanisms, and prevention. Am J Med. 1990; 88: 33-42. Ref.: https://goo.gl/uPMqmV
  20. Appelbaum  PC.  Antimicrobial  resistance  in  Streptococcus  pneumoniae:  an overview. Clin Infect Dis. 1992; 15: 77-83. Ref.: https://goo.gl/GcZTXc
  21. Kuranaga N, Kinoshita M, Kawabata T, Shinomiya N, Seki S. A defective Th1 response  of  the  spleen  in  the  initial  phase  may  explain  why  splenectomy  helps prevent a Listeria infection. Clinical & Experimental Immunology. 2005; 140: 11-21. Ref.: https://goo.gl/NuiLAq
  22. Maus UA,  Waelsch K,  Kuziel WA,  Delbeck T,  Mack M, et al.  Monocytes  are  potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis. J Immunol. 2003; 170: 3273-3278. Ref.: https://goo.gl/sE7DzW
  23. Barroso DE,  Godoy  D,  Castiñeiras  TMPP,  Tulenko  MM,  Rebelo  MC, et al.  β-lactam  Resistance,  Serotype  Distribution,  and  Genotypes  of  Meningitis causing  Streptococcus  pneumoniae,  Rio  de  Janeiro,  Brazil.  The Pediatric İnfectious Disease Journal. 2012; 31: 30. Ref.: https://goo.gl/zCsCzm
  24. Weinmann M, Becker G, Einsele H, Bamberg M. Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders. Radiother Oncol. 2001; 58: 235-246. Ref.: https://goo.gl/HcErhi
  25. Paulino AC, Reddy SP. Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders. Am J Hosp Palliat Care. 1996; 13: 32-35. Ref.: https://goo.gl/ZPQxCK
  26. Bouabdallah R, Coso D, Gonzague-Casabianca L, et al. Safety and efficacy of splenic irradiation in the treatment of patients with idiopathic myelofibrosis: a report on 15 patients. Leukemia Research. 2000; 24: 491-495.
  27. Dailey  MO,  Coleman  CN,  Kaplan  HS. Radiation-induced  splenic  atrophy  in  patients with Hodgkin’s disease and non-Hodgkin’s lymphomas. N Engl J Med. 1980; 302: 215-217. Ref.: https://goo.gl/bAaGAX
  28. Wagner H, McKeough PG, Desforges J, MadocJones H. Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia: results of daily and intermittent fractionation with and without concomitant hydroxyurea. Cancer. 1986; 58: 1207. Ref.: https://goo.gl/AnQACg
  29. Murray RG. The spleen. Histopathology of Irradiation (W. Bloom ed.) p.243. McGraw-Hill; New York. 1948.
  30. Spencer RP, Pearson HA. Splenic radiocolloid uptake in the presence of circulating Howell-Jolly bodies. J Nucl Med. 1973; 15: 294-295. Ref.: https://goo.gl/KgAAuT
  31. Looareesuwan S, Suntharasamai P, Webster HK, Ho M. Malaria in splenectomized patients: report of four cases and review. Clin Infect Dis. 1993; 16: 361-366. Ref.: https://goo.gl/yvGj24   
  32. Coleman CN, McDougall IR, Dailey MO, Ager P, Bush S, et al. Stanford, California. Functional Hyposplenia After Splenic Irradiation for Hodgkin's Disease. Ann Intern Med. 1982; 96: 44-47. Ref.:  https://goo.gl/NF1mKT
  33. Paulino AC, Reddy SP. Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders. Am J Hosp Palliat Care. 1996; 13: 32-35. Ref.: https://goo.gl/8ZmDyN
  34. Weinmann M, Becker G, Einsele H, Bamberg M. Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders. Radiother Oncol. 2001; 58: 235-246. Ref.: https://goo.gl/TE3qcH
  35. de Porto AP, Lammers AJ, Bennink RJ, ten Berge IJ, Speelman P, et al. Assessment of splenic function. Eur J Clin Microbiol Infect Dis. 2010; 29: 1465-1473. Ref.: https://goo.gl/Bz33J9
  36. McFarland JT, Kuzma C, Millard FE, Johnstone PA. Palliative irradiation of the spleen. Am J Clin Oncol. 2003; 26: 178-183. Ref.: https://goo.gl/zSni8u
  37. Elliott MA, Chen MG, Silverstein MN, Tefferi A. Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia. Br J Hematol. 1998; 103: 505. Ref.: https://goo.gl/eLZKGU
  38. Permentier C, Charbord P, Tibi M, Tubiana M. Splenic irradiation in myelofibrosis. Clinical findings and ferrokinetics. Int J Radiat Oncol Biol Phys. 1977; 2: 1075. Ref.: https://goo.gl/joAwxk
  39. Crary SE, Buchanan GR. Vascular complications after splenectomy for hematologic disorders. Blood. 2009; 114: 2861-2868. Ref.: https://goo.gl/HmEk5q
  40. Dailey MO, Coleman CN, Kaplan HS. Radiation-induced splenic atrophy in patients with Hodgkin’s disease and non-Hodgkin’s lymphomas. N Engl J Med. 1980; 302: 215-217. Ref.: https://goo.gl/mDTN8c
  41. Ugel S, Peranzoni E, Desantis G, Chioda M, Walter S, et al. Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. Cell Rep. 2012; 2: 628-639. Ref.: https://goo.gl/frXK9Q
  42. Srisajjakul S, Prapaisilp P, Laorratkul N. Normal Splenic Volume Assessment on CT in 426 Adults. Siriraj Medical Journal. 2012; 64: 43-46.
  43. Gatenby PA, Mudan SS, Wotherspoon AC. Splenectomy for non-haematological metastatic malignant disease. Langenbecks Arch Surg. 2011; 396: 625-638. Ref.: https://goo.gl/huWxaQ
  44. Weinmann M, Becker G, Einsele H, Bamberg M. Clinical Indications and Biological Mechanisms of Splenic Irradiation in Autoimmune Diseases. Strahlentherapie und Onkologie January. 2001; 177: 105-111. Ref.:  https://goo.gl/ELU5n9
  45. Markus H, Forfar JC. Splenic irradiation in treating warm autoimmune hemolytic anaemia. Br Med J Clin Res Ed. 1986; 293: 839-840. Ref.:  https://goo.gl/eHEgr7

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?